Translational Neurodegeneration

This review provides basic conceptual information on the molecular mechanisms underlying Parkinson’s Disease, which may assist in the design of more effective drugs or other treatment strategies.

Read the article

Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China 

The publication costs for Translational Neurodegeneration are fully covered by Ruijin Hospital, Shanghai Jiaotong University School of Medicine until 31st July 2018. For new submissions from 1st August 2018, authors will need to pay an article publishing charge (APC) of £1375.00/$2145.00/€1745.00 for each article submitted and accepted for publication in the journal.

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Read more

The publication costs for Translational Neurodegeneration are covered by Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China, so authors do not need to pay an article-processing charge for each article accepted for publication.

Update on Amyotrophic lateral sclerosis: from genetic and mitochondria perspective
Edited by Shengdi Chen and Jialin Zheng

Pharmacological treatment for early and advanced stages of Parkinson’s disease: current and future strategies
Edited by Shengdi Chen and Jialin Zheng